Lnc-PLCB1 is stabilized by METTL14 induced m6A modification and inhibits Helicobacter pylori mediated gastric cancer by destabilizing DDX21
View abstract on PubMed
Summary
This summary is machine-generated.Helicobacter pylori infection lowers lnc-PLCB1 levels in gastric cancer (GC) via m6A modification. This lncRNA suppresses tumor growth, offering a new therapeutic target for H. pylori-associated GC.
Area Of Science
- Oncology
- Molecular Biology
- Gastroenterology
Background
- Helicobacter pylori (H. pylori) infection is a major risk factor for gastric cancer (GC).
- Long noncoding RNAs (lncRNAs) and N6-methyladenosine (m6A) modification are implicated in GC development.
- The interplay between H. pylori, lncRNAs, and m6A in GC pathogenesis remains largely unexplored.
Purpose Of The Study
- To investigate the role of lncRNA m6A modification in H. pylori-mediated gastric cancer development.
- To elucidate the regulatory mechanism of lnc-PLCB1 in GC progression.
- To identify potential therapeutic targets for H. pylori-associated GC.
Main Methods
- Analysis of lnc-PLCB1 expression in GC tissues and cell lines.
- Investigation of the regulatory effects of H. pylori infection on lnc-PLCB1 expression.
- Assessment of the impact of lnc-PLCB1 overexpression or downregulation on GC cell proliferation and migration.
- Exploration of the molecular interactions involving METTL14, IRF2, lnc-PLCB1, DDX21, CCND1, and Slug.
Main Results
- H. pylori infection downregulates lnc-PLCB1 expression through METTL14-mediated m6A modification and IRF2-mediated transcriptional regulation.
- Overexpression of lnc-PLCB1 inhibits GC cell proliferation and migration, while its downregulation promotes these processes.
- lnc-PLCB1 expression is significantly lower in GC tissues compared to normal tissues.
- lnc-PLCB1 reduces the protein stability of DDX21, subsequently downregulating CCND1 and Slug expression, thereby exerting tumor-suppressive effects.
Conclusions
- The METTL14/lnc-PLCB1/DDX21 axis is crucial in H. pylori-mediated gastric cancer.
- lnc-PLCB1 functions as a tumor suppressor in GC development.
- lnc-PLCB1 represents a promising novel therapeutic target for treating H. pylori-associated gastric cancer.
Related Concept Videos
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...

